Mirai logo

3476 - Mirai News Story

¥34150 200.0  0.6%

Last Trade - 07/08/20

Sector
Financials
Size
Mid Cap
Market Cap £409.1m
Enterprise Value £951.9m
Revenue £77.8m
Position in Universe 1000th / 3862

Russia's RDIF to invest in coronavirus tests developer Medpromresurs

Thu 19th March, 2020 1:15pm
MOSCOW, March 19 (Reuters) - The Russian Direct Investment
Fund (RDIF) said on Thursday it will invest in Medpromresurs, a
Russian company that is currently developing coronavirus tests.
    RDIF said that its partners in Medpromresurs, established to
focus on a new Russian-Japanese diagnostic system for
coronavirus, are Japan's К.R. Mirai Genomics and two other
Russian firms. 
    

 (Reporting by Anton Kolodyazhnyy; writing by Katya Golubkova;
editing by Jason Neely)
 ((ekaterina.golubkova@thomsonreuters.com; +7 495 775 1242;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.